A Case Study:  "Therapeutic Targeting of Sphingolipid Signaling in Experimental Stroke"

Weill Cornell Medicine, Tri-I TDI and Bridge Medicines Advancing Human Health

Teresa Sanchez Garcia Vao, Ph.D.
Weill Cornell Medicine

Michael Foley, Ph.D.
Tri-I TDI

William Polvino, M.D.
Bridge Medicines

Tuesday, February 13 at 4:00pm to 5:00pm

Belfer Research Building, 302 C/D
413 East 69th St., New York, NY 10021

Event Type

Lecture/Seminar, Tri-Institutional Event

Departments

Tri-Institutional Therapeutics Discovery Institute

Cost

Free

Subscribe
Google Calendar iCal Outlook

Recent Activity